Literature DB >> 11929804

What do oncogenic mutations have to do with angiogenesis/vascular dependence of tumors?

Janusz Rak1, Joanne L Yu, Robert S Kerbel, Brenda L Coomber.   

Abstract

Entities:  

Mesh：

Year:  2002        PMID： 11929804

Source DB:  PubMed          Journal:  Cancer Res        ISSN： 0008-5472            Impact factor:   12.701


× No keyword cloud information.
  22 in total

1.  Angiogenesis and melanoma - from basic science to clinical trials.

Authors:  Maxine Sylvia Emmett; Daemon Dewing; Rowan Oliver Pritchard-Jones
Journal:  Am J Cancer Res       Date:  2011-08-08       Impact factor: 6.166

2.  Augmentation of tumor angiogenesis by a Myc-activated microRNA cluster.

Authors:  Michael Dews; Asal Homayouni; Duonan Yu; Danielle Murphy; Cinzia Sevignani; Erik Wentzel; Emma E Furth; William M Lee; Greg H Enders; Joshua T Mendell; Andrei Thomas-Tikhonenko
Journal:  Nat Genet       Date:  2006-07-30       Impact factor: 38.330

3.  Targeting oncogenic serine/threonine-protein kinase BRAF in cancer cells inhibits angiogenesis and abrogates hypoxia.

Authors:  Alessia Bottos; Miriam Martini; Federica Di Nicolantonio; Valentina Comunanza; Federica Maione; Alberto Minassi; Giovanni Appendino; Federico Bussolino; Alberto Bardelli
Journal:  Proc Natl Acad Sci U S A       Date:  2011-12-27       Impact factor: 11.205

4.  Carbonic anhydrase IX expression is associated with favorable prognostic factors in small intestinal carcinoma.

Authors:  Mi Jin Gu; Kye Won Kwon
Journal:  J Histochem Cytochem       Date:  2013-11-11       Impact factor: 2.479

Review 5.  The role of platelets in tumour growth.

Authors:  K Pilatova; L Zdrazilova-Dubska; G L Klement
Journal:  Klin Onkol       Date:  2012

6.  Minimally invasive colon resection is associated with a transient increase in plasma sVEGFR1 levels and a decrease in sVEGFR2 levels during the early postoperative period.

Authors:  H M C Shantha Kumara; J C Cabot; A Hoffman; M Luchtefeld; M F Kalady; N Hyman; D Feingold; R Baxter; R Larry Whelan
Journal:  Surg Endosc       Date:  2009-01-28       Impact factor: 4.584

7.  High levels of carbonic anhydrase IX in tumour tissue and plasma are biomarkers of poor prognostic in patients with non-small cell lung cancer.

Authors:  M Ilie; N M Mazure; V Hofman; R E Ammadi; C Ortholan; C Bonnetaud; K Havet; N Venissac; B Mograbi; J Mouroux; J Pouysségur; P Hofman
Journal:  Br J Cancer       Date:  2010-05-11       Impact factor: 7.640

8.  Contrasting effects of VEGF gene disruption in embryonic stem cell-derived versus oncogene-induced tumors.

Authors:  Alicia Viloria-Petit; Lucile Miquerol; Joanne L Yu; Marina Gertsenstein; Capucine Sheehan; Linda May; Jack Henkin; Corrinne Lobe; Andras Nagy; Robert S Kerbel; Janusz Rak
Journal:  EMBO J       Date:  2003-08-15       Impact factor: 11.598

9.  Sp1 is involved in Akt-mediated induction of VEGF expression through an HIF-1-independent mechanism.

Authors:  Nabendu Pore; Shuang Liu; Hui-Kuo Shu; Bin Li; Daphne Haas-Kogan; David Stokoe; Julie Milanini-Mongiat; Gilles Pages; Donald M O'Rourke; Eric Bernhard; Amit Maity
Journal:  Mol Biol Cell       Date:  2004-09-01       Impact factor: 4.138

10.  Overexpression of RRM2 decreases thrombspondin-1 and increases VEGF production in human cancer cells in vitro and in vivo: implication of RRM2 in angiogenesis.

Authors:  Keqiang Zhang; Shuya Hu; Jun Wu; Linling Chen; Jianming Lu; Xiaochen Wang; Xiyong Liu; Bingsen Zhou; Yun Yen
Journal:  Mol Cancer       Date:  2009-02-28       Impact factor: 27.401
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.